Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Haemophilia

02 3Haemophilia A

03 2NovoSeven

04 1of which Novoseven

PharmaCompass

01

arrow
iPHEX India
Not Confirmed

02

Brand Name : Haemophilia A

Recombinant Human Coagulation Factor VIIa

arrow
iPHEX India
Not Confirmed

03

Brand Name : Haemophilia A

Recombinant Human Coagulation Factor VIIa

arrow
iPHEX India
Not Confirmed

04

Brand Name : NovoSeven

Recombinant Coagulation Factor VIIa

arrow
iPHEX India
Not Confirmed

05

Brand Name : Haemophilia A

Recombinant Human Coagulation Factor VIIa

arrow
iPHEX India
Not Confirmed

06

Brand Name : NovoSeven

Recombinant Coagulation Factor VIIa

arrow
iPHEX India
Not Confirmed

Brand Name : NovoSeven

arrow
iPHEX India
Not Confirmed

Recombinant Coagulation Factor VIIa

Main Therapeutic Indication : Rare Diseases and Disorders

Currency : USD

2024 Revenue in Millions : 1,107

2023 Revenue in Millions : 1,157

Growth (%) : -4

blank

07

arrow
iPHEX India
Not Confirmed

08

Brand Name : of which Novoseven

Coagulation Factor VII [Recombinant]

arrow
iPHEX India
Not Confirmed

Brand Name : of which Novoseven

arrow
iPHEX India
Not Confirmed

Coagulation Factor VII [Recombinant]

Main Therapeutic Indication : Blood Disorders

Currency : USD

2018 Revenue in Millions : 1,182

2017 Revenue in Millions : 1,381

Growth (%) : -14%

blank

09

arrow
iPHEX India
Not Confirmed